Image Credit:Nephro-Urol Mon
Outline
Chronic Hemodialysis Patients; Special Group for Hepatitis C Elimination Programs in Iran
Footnotes
Authors’ Contribution:Both authors contributed equally in this manuscript.
Conflict of Interests:Authors declared no conflict of interests.
Funding/Support:There is no financial support.
References
- 1.Lancet T. Towards elimination of viral hepatitis by 2030. Elsevier; 2016.
- 2.Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepat Mon. 2016;16(4):37089. [PubMed ID: 27275164]. https://doi.org/10.5812/hepatmon.37089.
- 3.Mirminachi B, Mohammadi Z, Merat S, Neishabouri A, Sharifi AH, Alavian SH. Update on the prevalence of hepatitis c virus infection among iranian general population: A systematic review and meta-analysis. Hepat Mon. 2017;17(2).
- 4.Makhlough A, Mahdavi M, Maleki I, Davoodi L, Mousavi T, Hasani-Mansoor SH, et al. The prevalence of hcv infection in hemodialysis population and compared elisa and pcr methods for detecting of hcv infection. Nephro-Urol Mon. 2017;In press(In press). https://doi.org/10.5812/numonthly.45144.
- 5.Abad S, Vega A, Hernandez E, Merida E, de Sequera P, Albalate M, et al. Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4. Am J Nephrol. 2017;45(3):267-72. [PubMed ID: 28166520]. https://doi.org/10.1159/000454819.
- 6.Saab S, A. Jimenez M, N. Bau S, Choi G, Durazo FA, M. El-Kabany M, et al. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis. J Clin Gastroenterol. 2017;51(2):167-73. [PubMed ID: 27548734]. https://doi.org/10.1097/MCG.0000000000000640.
- 7.Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, et al. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepat Mon. 2016;16(8):40959. [PubMed ID: 27799966]. https://doi.org/10.5812/hepatmon.guideline.
- 8.Einollahi B, Alavian SM. Hepatitis C virus infection and kidney transplantation: a review for clinicians. Iran J Kidney Dis. 2010;4(1):1-8. [PubMed ID: 20081297].
- 9.Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, et al. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol. 2007;18(5):1584-93. [PubMed ID: 17429053]. https://doi.org/10.1681/ASN.2006070736.
Copyright
Copyright © 2017, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Similar Articles
Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)
Jabbari A, Besharat S, Khodabakhshi B. Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005). Hepat Mon. 2008;8(1):. doi:
Elimination of Hepatitis C Virus Infection Among Hemodialysis Patients Will Be Possible If All Patients Undergo Treatment
Alavian SM. Elimination of Hepatitis C Virus Infection Among Hemodialysis Patients Will Be Possible If All Patients Undergo Treatment. Int J Infect. 2018;5(4):e69025. doi: https://doi.org/10.5812/iji.69025
Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients
Nakhaie M, Taheri E, Charostad J, Arefinia N, Kalantar-Neyestanaki D, et al. Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients. Jundishapur J Microbiol. 2023;16(5):e136504. doi: https://doi.org/10.5812/jjm-136504
Prevalence and Risk Factors of Hepatitis C infection in hemodialysis Patients (Kermanshah , 1999 – 2000)
Sabour B, Boromand P, Mehrabi Y, Ghanbari M, Zarrinfam H. Prevalence and Risk Factors of Hepatitis C infection in hemodialysis Patients (Kermanshah , 1999 – 2000). J Kermanshah Univ Med Sci. 2003;7(3):e81264. doi:
Controversial Report Regarding Seroprevalence of Hepatitis B and C Viruses Among Hemodialysis Patients In Kerman Province, South-East Iran
Noroozi Karimabad M, Hassanshahi G, Arababadi MK. Controversial Report Regarding Seroprevalence of Hepatitis B and C Viruses Among Hemodialysis Patients In Kerman Province, South-East Iran. Hepat Mon. 2013;13(3):e7046. doi: https://doi.org/10.5812/hepatmon.7046
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 1 week ago
- OpenAlex: 0
Last Update: 2 days ago
- OpenCitations: 0
Last Update: 5 days ago